Grant to help countries develop drug and vaccine programs to be used globally BOSTON, MA — Management Sciences for Health (MSH) will use a $29.9 million grant from the Bill & Melinda Gates Foundation to improve the drug supply systems of developing countries and create new public-private models that will promote sustainable, equitable access to priority drugs and vaccines throughout the world.

Money will pay for three new programs aimed at improving health in developing countriesBOSTON, MA (OCTOBER 1, 2000) — Management Sciences for Health (MSH) has been awarded funding totaling $186 million by the United States Agency for International Development (USAID) for three new projects. These worldwide projects will expand and improve reproductive health and AIDS programs in Africa; strengthen the management and leadership of health services in developing countries; and increase access to commodities such as drugs, vaccines and contraceptives in those countries.

International conference assembles leading pharmaceutical experts from over 15 countriesGENEVA, SWITZERLAND (DECEMBER 26, 2000) — The World Health Organization (WHO) and Management Sciences for Health (MSH) will begin testing new drug access indicators in six developing countries early next year. Developed at a major international conference hosted by WHO and MSH from 11-13 December in Geneva, these indicators will measure five aspects of drug access - availability, geographic accessibility, affordability, acceptability/satisfaction, and quality of product and service.